|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
41,590,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$31.99 - $31.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Veitinger Klaus R Dr |
Director |
|
2014-08-11 |
4 |
OE |
$4.65 |
$19,377 |
D/D |
4,167 |
6,879 |
|
- |
|
Lockey Claire |
See Remarks |
|
2014-08-08 |
4 |
AS |
$25.00 |
$265,000 |
D/D |
(10,000) |
0 |
|
- |
|
Lockey Claire |
See Remarks |
|
2014-08-08 |
4 |
OE |
$4.65 |
$46,500 |
D/D |
10,000 |
10,000 |
|
- |
|
Stahl Wilhelm |
SVP, Pharmaceutical Operations |
|
2014-08-08 |
4 |
AS |
$25.09 |
$1,237,085 |
D/D |
(49,300) |
0 |
|
- |
|
Stahl Wilhelm |
SVP, Pharmaceutical Operations |
|
2014-08-08 |
4 |
OE |
$3.96 |
$195,228 |
D/D |
49,300 |
49,300 |
|
- |
|
Berman Lance |
Chief Medical Officer and SVP |
|
2014-07-24 |
4 |
AS |
$23.78 |
$357,896 |
D/D |
(15,000) |
0 |
|
- |
|
Berman Lance |
Chief Medical Officer and SVP |
|
2014-07-24 |
4 |
OE |
$3.96 |
$59,400 |
D/D |
15,000 |
15,000 |
|
- |
|
Berman Lance |
Chief Medical Officer and SVP |
|
2014-07-23 |
4 |
AS |
$24.23 |
$363,622 |
D/D |
(15,000) |
0 |
|
- |
|
Berman Lance |
Chief Medical Officer and SVP |
|
2014-07-23 |
4 |
OE |
$3.96 |
$59,400 |
D/D |
15,000 |
15,000 |
|
- |
|
Berman Lance |
Chief Medical Officer and SVP |
|
2014-07-22 |
4 |
AS |
$23.67 |
$354,993 |
D/D |
(15,000) |
0 |
|
- |
|
Berman Lance |
Chief Medical Officer and SVP |
|
2014-07-22 |
4 |
OE |
$3.96 |
$59,400 |
D/D |
15,000 |
15,000 |
|
- |
|
Veitinger Klaus R Dr |
Director |
|
2014-07-10 |
4 |
AS |
$23.12 |
$96,354 |
D/D |
(4,167) |
2,712 |
|
- |
|
Veitinger Klaus R Dr |
Director |
|
2014-07-10 |
4 |
OE |
$4.65 |
$19,377 |
D/D |
4,167 |
6,879 |
|
- |
|
Veitinger Klaus R Dr |
Director |
|
2014-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,712 |
2,712 |
|
- |
|
Schuetz Thomas J. |
Director |
|
2014-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,712 |
2,712 |
|
- |
|
Mcgirr David W J |
Director |
|
2014-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,712 |
2,712 |
|
- |
|
Butler John P. |
Director |
|
2014-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,712 |
2,712 |
|
- |
|
Hastings Paul J |
Director |
|
2014-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,712 |
2,712 |
|
- |
|
243 Records found
|
|
Page 10 of 10 |
|
|